{"url_path":"/sec/imux/8-k/2026-08-11/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-001071-index.html","accession_number":"0001193805-26-001071","cik":"0001280776","ticker":"IMUX","issuer_name":"IMMUNIC, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-001071-index.html","primary_entity_key":"0001280776","primary_entity_name":"IMMUNIC, INC."},"word_count":132,"has_tables":true,"body_markdown":"**Item 7.01 Regulation FD Disclosure.**\n\n** **\n\nOn August 10, 2026, the Company\nissued a press release announcing the appointment of Ms. Ridloff. A copy of the press release is furnished as Exhibit 99.2 hereto and\nis incorporated herein by reference. The information set forth in this Item 7.01 and in Exhibit 99.2 is furnished and shall not be deemed\n“filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information\nin this Item 7.01 and in Exhibit 99.2 shall not be deemed to be incorporated by reference into any filing of the Company under the Securities\nAct, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in\nsuch a filing."}